Almatica Pharma
NJ - Morristown
PharmaceuticalFocus: Small Molecules
Almatica Pharma is a life sciences company focused on Small Molecules.
NeurologyInfectious DiseasesCardiovascularPsychiatry
Funding Stage
PUBLIC
Open Jobs
11
Products & Portfolio (11)
CITALOPRAM HYDROBROMIDE
citalopram
Peak
ORAL · CAPSULE
unclear, but is presumed to be related to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Major Depressive Disorder (MDD) in adults
2022
30
DULOXETINE
duloxetine
Launch
CAPSULE, DELAYED RELEASE
antidepressant, central pain inhibitory and anxiolytic actions of duloxetine in humans are unknown, these actions are believed to be related to its potentiation of serotonergic and noradrenergic activity in the CNS.
the following conditions: Major depressive disorder (MDD) in adults ( ) Generalized anxiety disorder (GAD) in adultsolder ( ) Diabetic peripheral neuropathic pain (DPNP) in adults ( ) Fibromyalgia (FM) in adultsolder ( ) Chronic musculoskeletal pain in adults ( )+1 more
2026
30
ESCITALOPRAM
escitalopram
Launch
ORAL · CAPSULE
escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
anxiety
2025
30
GRALISE
gabapentin
LOE Approaching
ORAL · TABLET
analgesia, gabapentin prevents allodynia (pain-related behavior in response to a normally innocuous stimulus) and hyperalgesia (exaggerated response to painful stimuli). Gabapentin prevents pain-related responses in several models of neuropathic pain in rats and mice (e.g., spinal nerve ligation models, spinal cord injury model, acute herpes zoster infection model). Gabapentin also decreases pain-related responses after peripheral inflammation (carrageenan footpad test, late phase of formulin test), but does not alter immediate pain-related behaviors (rat tail flick test, formalin footpad acute phase). The relevance of these models to human pain is not known. Gabapentin is structurally related to the neurotransmitter GABA (gamma-aminobutyric acid), but it does not modify GABA A or GABA B radioligand binding, it is not converted metabolically into GABA or a GABA agonist, and it is not an inhibitor of GABA uptake or degradation. In radioligand binding assays at concentrations up to 100 μM, gabapentin did not exhibit affinity for a number of other receptor sites, including benzodiazepine, glutamate, N-methyl-D-aspartate (NMDA), quisqualate, kainate, strychnine-insensitive or strychnine-sensitive glycine; alpha 1, alpha 2, or beta adrenergic; adenosine A1 or A2; cholinergic, muscarinic, or nicotinic; dopamine D1 or D2; histamine H1; serotonin S1 or S2; opiate mu, delta, or kappa; cannabinoid 1; voltage-sensitive calcium channel sites labeled with nitrendipine or diltiazem; or at voltage-sensitive sodium channel sites labeled with batrachotoxinin A20-alpha-benzoate. Gabapentin did not alter the cellular uptake of dopamine, noradrenaline, or serotonin. In vitro studies with radiolabeled gabapentin have revealed a gabapentin binding site in areas of rat brain including neocortex and hippocampus. A high-affinity binding protein in animal brain tissue has been identified as an auxiliary subunit of voltage-activated calcium channels. However, functional correlates of gabapentin binding, if any, remain to be elucidated. It is hypothesized that gabapentin antagonizes thrombospondin binding to α2δ-1 as a receptor involved in excitatory synapse formation and suggested that gabapentin may function therapeutically by blocking new synapse formation.
Postherpetic Neuralgia (PHN)
2011
30
LOREEV XR
lorazepam
Peak
ORAL · CAPSULE, EXTENDED RELEASE
gamma-aminobutyric acid-A (GABA A ) receptors in the brain and enhances GABA-mediated synaptic inhibition.
anxiety disorders in adultsevenly dividedthree times daily dosing with lorazepam tablets ()+1 more
2021
0
MACROBID
nitrofurantoin monohydrate/macrocrystalline
LOE Approaching
ORAL · CAPSULE
Mechanism of Action The mechanism of the antimicrobial action of nitrofurantoin is unusual among antibacterials. Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates which inactivate or alter bacterial ribosomal proteins and other macromolecules. As a result of such inactivations, the vital biochemical processes of protein synthesis, aerobic energy metabolism, DNA synthesis, RNA synthesis, and cell wall synthesis are inhibited. Nitrofurantoin is bactericidal in urine at therapeutic doses. The broad-based nature of this mode of action may explain the lack of acquired bacterial resistance to nitrofurantoin, as the necessary multiple and simultaneous mutations of the target macromolecules would likely be lethal to the bacteria.
pyelonephritisperinephric abscesses
1991
30
MACRODANTIN
nitrofurantoin macrocrystals
LOE Approaching
ORAL · CAPSULE
Mechanism of Action The mechanism of the antimicrobial action of nitrofurantoin is unusual among antibacterials. Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates which inactivate or alter bacterial ribosomal proteins and other acromolecules. As a result of such inactivations, the vital biochemical processes of protein synthesis, aerobic energy metabolism, DNA synthesis, RNA synthesis, and cell wall synthesis are inhibited. Nitrofurantoin is bactericidal in urine at therapeutic doses. The broad-based nature of this mode of action may explain the lack of acquired bacterial resistance to nitrofurantoin, as the necessary multiple and simultaneous mutations of the target macromolecules would likely be lethal to the bacteria.
urinary tract infectionsenterococciStaphylococcus aureus+4 more
1970
30
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
Peak
ORAL · CAPSULE
2021
30
VENLAFAXINE BESYLATE
venlafaxine
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
2022
15
ZESTORETIC
lisinopril and hydrochlorothiazide
LOE Approaching
ORAL · TABLET
1989
30
ZOLPIDEM TARTRATE
zolpidem tartrate
Growth
ORAL · CAPSULE
2023
30
Open Jobs (11)
Water - Wastewater FM Technician
Norwich, NY, US
4h ago
$35 - $41/yr
Government Pricing Intern
Morristown, NJ, US
4d ago
Up to $20/yr
Supply Chain Intern
Morristown, NJ, US
4d ago
Up to $20/yr
Control Center Technician I
Norwich, NY, Norwich, NY, US
1w ago
$18 - $20/yr
Chemist I
Norwich, NY, Norwich, NY, US
1w ago
$62K/yr
Facilities Maintenance Controls E&I Technician
Norwich, NY, US
Technician2w ago
$24 - $44/yr
Combination Product Manager, R&D
Pinebrook, NJ, US
Research & Development4w ago
$130K - $140K/yr
Associate Director, Legal Affairs
Morristown, NJ, US
Legal & IP1mo ago
$160K - $185K/yr
Packaging Technician
Norwich, NY, Norwich, NY, US
Technician2mo ago
$18/yr
Manufacturing Technician
Norwich, NY, Norwich, NY, US
Technician5mo ago
$18/yr
Associate Director Clinical Research & Develo
Pinebrook, NJ, US
Clinical7mo ago
$150K - $175K/yr
Interview Prep Quick Facts
Founded: 2024
Portfolio: 11 approved products
Top TAs: Neurology, Infectious Diseases, Cardiovascular
Open Roles: 11 active jobs
Portfolio Health
Launch2 (18%)
Growth1 (9%)
Peak3 (27%)
LOE Approaching5 (45%)
11 total products
Therapeutic Area Focus
Marketed
Pipeline
Hiring Trend
Actively Hiring
11
Open Roles
+11
Added
-0
Filled/Removed
Based on last 4 crawl cycles